BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36076593)

  • 1. Upregulation of PARG in prostate cancer cells suppresses their malignant behavior and downregulates tumor-promoting genes.
    Karpova Y; Johnson SJ; Bordet G; Guo D; Ghatak A; Markov DA; Tulin AV
    Biomed Pharmacother; 2022 Sep; 153():113504. PubMed ID: 36076593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PARG suppresses tumorigenesis and downregulates genes controlling angiogenesis, inflammatory response, and immune cell recruitment.
    Johnson S; Karpova Y; Guo D; Ghatak A; Markov DA; Tulin AV
    BMC Cancer; 2022 May; 22(1):557. PubMed ID: 35585513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial and functional relationship between poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in the brain.
    Poitras MF; Koh DW; Yu SW; Andrabi SA; Mandir AS; Poirier GG; Dawson VL; Dawson TM
    Neuroscience; 2007 Aug; 148(1):198-211. PubMed ID: 17640816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global analysis of transcriptional regulation by poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in MCF-7 human breast cancer cells.
    Frizzell KM; Gamble MJ; Berrocal JG; Zhang T; Krishnakumar R; Cen Y; Sauve AA; Kraus WL
    J Biol Chem; 2009 Dec; 284(49):33926-38. PubMed ID: 19812418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARG Inhibitors and Functional PARG Inhibition Models.
    Sasaki Y; Hozumi M; Fujimori H; Murakami Y; Koizumi F; Inoue K; Masutani M
    Curr Protein Pept Sci; 2016; 17(7):641-653. PubMed ID: 27817742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered poly(ADP-ribose) metabolism impairs cellular responses to genotoxic stress in a hypomorphic mutant of poly(ADP-ribose) glycohydrolase.
    Gao H; Coyle DL; Meyer-Ficca ML; Meyer RG; Jacobson EL; Wang ZQ; Jacobson MK
    Exp Cell Res; 2007 Mar; 313(5):984-96. PubMed ID: 17276427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of poly(ADP-ribose) polymerase-1 or poly(ADP‑ribose) glycohydrolase individually, but not in combination, leads to improved chemotherapeutic efficacy in HeLa cells.
    Feng X; Koh DW
    Int J Oncol; 2013 Feb; 42(2):749-56. PubMed ID: 23254695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine-tuning of Smad protein function by poly(ADP-ribose) polymerases and poly(ADP-ribose) glycohydrolase during transforming growth factor β signaling.
    Dahl M; Maturi V; Lönn P; Papoutsoglou P; Zieba A; Vanlandewijck M; van der Heide LP; Watanabe Y; Söderberg O; Hottiger MO; Heldin CH; Moustakas A
    PLoS One; 2014; 9(8):e103651. PubMed ID: 25133494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism.
    Davidovic L; Vodenicharov M; Affar EB; Poirier GG
    Exp Cell Res; 2001 Aug; 268(1):7-13. PubMed ID: 11461113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen Receptor and Poly(ADP-ribose) Glycohydrolase Inhibition Increases Efficiency of Androgen Ablation in Prostate Cancer Cells.
    Zhang M; Lai Y; Vasquez JL; James DI; Smith KM; Waddell ID; Ogilvie DJ; Liu Y; Agoulnik IU
    Sci Rep; 2020 Mar; 10(1):3836. PubMed ID: 32123273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drosophila poly(ADP-ribose) glycohydrolase mediates chromatin structure and SIR2-dependent silencing.
    Tulin A; Naumova NM; Menon AK; Spradling AC
    Genetics; 2006 Jan; 172(1):363-71. PubMed ID: 16219773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of poly(ADP-ribose) glycohydrolase in wild-type and PARG-110 knock-out retina.
    Sahaboglu A; Bolz S; Löwenheim H; Paquet-Durand F
    Adv Exp Med Biol; 2014; 801():463-9. PubMed ID: 24664732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-ribose) accumulation and enhancement of postischemic brain damage in 110-kDa poly(ADP-ribose) glycohydrolase null mice.
    Cozzi A; Cipriani G; Fossati S; Faraco G; Formentini L; Min W; Cortes U; Wang ZQ; Moroni F; Chiarugi A
    J Cereb Blood Flow Metab; 2006 May; 26(5):684-95. PubMed ID: 16177811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) - Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy.
    Harrision D; Gravells P; Thompson R; Bryant HE
    Front Mol Biosci; 2020; 7():191. PubMed ID: 33005627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective down-regulation of nuclear poly(ADP-ribose) glycohydrolase.
    Burns DM; Ying W; Kauppinen TM; Zhu K; Swanson RA
    PLoS One; 2009; 4(3):e4896. PubMed ID: 19319190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disrupted ADP-ribose metabolism with nuclear Poly (ADP-ribose) accumulation leads to different cell death pathways in presence of hydrogen peroxide in procyclic Trypanosoma brucei.
    Schlesinger M; Vilchez Larrea SC; Haikarainen T; Narwal M; Venkannagari H; Flawiá MM; Lehtiö L; Fernández Villamil SH
    Parasit Vectors; 2016 Mar; 9():173. PubMed ID: 27007296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Insights into the Roles of NAD+-Poly(ADP-ribose) Metabolism and Poly(ADP-ribose) Glycohydrolase.
    Tanuma S; Sato A; Oyama T; Yoshimori A; Abe H; Uchiumi F
    Curr Protein Pept Sci; 2016; 17(7):668-682. PubMed ID: 27817743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic activity of poly (ADP-ribose) glycohydrolase.
    Marques M; Jangal M; Wang LC; Kazanets A; da Silva SD; Zhao T; Lovato A; Yu H; Jie S; Del Rincon S; Mackey J; Damaraju S; Alaoui-Jamali M; Witcher M
    Oncogene; 2019 Mar; 38(12):2177-2191. PubMed ID: 30459355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ADP)-Ribosylation Inhibition: A Promising Approach for Clear Cell Renal Cell Carcinoma Therapy.
    Karpova Y; Guo D; Makhov P; Haines AM; Markov DA; Kolenko V; Tulin AV
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttranscriptional Regulation of
    Chand SN; Zarei M; Schiewer MJ; Kamath AR; Romeo C; Lal S; Cozzitorto JA; Nevler A; Scolaro L; Londin E; Jiang W; Meisner-Kober N; Pishvaian MJ; Knudsen KE; Yeo CJ; Pascal JM; Winter JM; Brody JR
    Cancer Res; 2017 Sep; 77(18):5011-5025. PubMed ID: 28687616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.